These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3478534)

  • 1. A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical results.
    Elias L; Hoffman R; Boswell S; Tensen L; Bonnem EM
    Leukemia; 1987 Feb; 1(2):105-10. PubMed ID: 3478534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of recombinant human interferon alpha in myelodysplastic syndromes.
    Nand S; Ellis T; Messmore H; Fisher SG; Gaynor E; Fisher RI
    Leukemia; 1992 Mar; 6(3):220-3. PubMed ID: 1564960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2b.
    Aul C; Gattermann N; Schneider W
    Eur J Haematol; 1991 Jan; 46(1):11-6. PubMed ID: 1988303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide for the treatment of patients with myelodysplastic syndromes.
    Strupp C; Germing U; Aivado M; Misgeld E; Haas R; Gattermann N
    Leukemia; 2002 Jan; 16(1):1-6. PubMed ID: 11840256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
    Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
    Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
    Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of recombinant alpha 2 interferon in the myelodysplastic syndrome: II. Characterization and response of granulocyte and platelet dysfunction.
    Elias L; Van Epps DE; Smith KJ; Savage B
    Leukemia; 1987 Feb; 1(2):111-5. PubMed ID: 2823014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.
    Chang KL; O'Donnell MR; Slovak ML; Dagis AC; Arber DA; Niland JC; Forman SJ
    Leukemia; 2002 Apr; 16(4):623-31. PubMed ID: 11960342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome: a study of prognostic factors.
    Lin JS; Lin CK; Liu SM; Chen LY; Wang SY
    J Formos Med Assoc; 1991 Mar; 90(3):232-9. PubMed ID: 1677397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M; Yamauchi H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary myelodysplastic syndrome: an analysis of 56 patients.
    Chen PH; Kuo CY; Huang CH; Shih LY
    Changgeng Yi Xue Za Zhi; 1992 Sep; 15(3):121-7. PubMed ID: 1468034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the haematologic spectrum of myelodysplastic syndrome.
    Kini J; Khadilkar UN; Dayal JP
    Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation of interferons in the preleukemic state (CML and MDS)].
    Koyama S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1191-7. PubMed ID: 3132893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
    Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
    Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
    Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
    Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.